News Home

Is Johnson & Johnson (JNJ) Stock About to Get Hot Wednesday?

Wednesday, January 26, 2022 10:15 AM | InvestorsObserver Analysts
Is Johnson & Johnson (JNJ) Stock About to Get Hot Wednesday?

The market has been high on Johnson & Johnson (JNJ) stock recently. JNJ gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Johnson & Johnson has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on JNJ!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With JNJ Stock Today?

Johnson & Johnson (JNJ) stock is trading at $168.14 as of 10:05 AM on Wednesday, Jan 26, a rise of $0.62, or 0.37% from the previous closing price of $167.52. The stock has traded between $167.18 and $169.03 so far today. Volume today is less active than usual. So far 704,353 shares have traded compared to average volume of 7,579,742 shares. To see InvestorsObserver's Sentiment Score for Johnson & Johnson click here.

More About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. Click Here to get the full Stock Report for Johnson & Johnson stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App